{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T07:51:15Z","timestamp":1776153075570,"version":"3.50.1"},"reference-count":189,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021778","name":"Agencia Nacional de Promoci\u00f3n de la Investigaci\u00f3n, el Desarrollo Tecnol\u00f3gico y la Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PICT-2020-00950"],"award-info":[{"award-number":["PICT-2020-00950"]}],"id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 11220200102210CO"],"award-info":[{"award-number":["PIP 11220200102210CO"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>The pituitary is a master gland responsible for the modulation of critical endocrine functions. Pituitary neuroendocrine tumours (PitNETs) display a considerable prevalence of 1\/1106, frequently observed as benign solid tumours. PitNETs still represent a cause of important morbidity, due to hormonal systemic deregulation, with surgical, radiological or chronic treatment required for illness management. The apparent scarceness, uncommon behaviour and molecular features of PitNETs have resulted in a relatively slow progress in depicting their pathogenesis. An appropriate interpretation of different phenotypes or cellular outcomes during tumour growth is desirable, since histopathological characterization still remains the main option for prognosis elucidation. Improved knowledge obtained in recent decades about pituitary tumorigenesis has revealed that this process involves several cellular routes in addition to proliferation and death, with its modulation depending on many signalling pathways rather than being the result of abnormalities of a unique proliferation pathway, as sometimes presented. PitNETs can display intrinsic heterogeneity and cell subpopulations with diverse biological, genetic and epigenetic particularities, including tumorigenic potential. Hence, to obtain a better understanding of PitNET growth new approaches are required and the systematization of the available data, with the role of cell death programs, autophagy, stem cells, cellular senescence, mitochondrial function, metabolic reprogramming still being emerging fields in pituitary research. We envisage that through the combination of molecular, genetic and epigenetic data, together with the improved morphological, biochemical, physiological and metabolically knowledge on pituitary neoplastic potential accumulated in recent decades, tumour classification schemes will become more accurate regarding tumour origin, behaviour and plausible clinical results.<\/jats:p>","DOI":"10.3389\/fendo.2022.924942","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T04:31:23Z","timestamp":1656390683000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Architects of Pituitary Tumour Growth"],"prefix":"10.3389","volume":"13","author":[{"given":"Maria Eugenia","family":"Sabatino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezequiel","family":"Grondona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Luc\u00eda","family":"De Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2020.04.002","article-title":"The Epidemiology of Pituitary Adenomas","volume":"49","author":"Daly","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.coemr.2018.01.004","article-title":"Molecular and Cellular Pathogenesis of Pituitary Tumors","volume":"1","author":"Stalla","year":"2018","journal-title":"Curr Opin Endocrine Metab Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1530\/ERC-11-0211","article-title":"RSUME is Implicated in HIF-1-Induced VEGF-A Production in Pituitary Tumour Cells","volume":"19","author":"Shan","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.gene.2016.12.012","article-title":"Relationship Between RSUME and HIF-1alpha\/VEGF-A With Invasion of Pituitary Adenoma","volume":"603","author":"He","year":"2017","journal-title":"Gene"},{"key":"B5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO Classification of Pituitary Tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr Pathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1677\/ERC-07-0062","article-title":"A Diagnostic Marker Set for Invasion, Proliferation, and Aggressiveness of Prolactin Pituitary Tumors","volume":"14","author":"Wierinckx","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.5772\/56028","article-title":"\"New Insights in the Pathogenesis of Pituitary Tumours,\"","volume-title":"Hot Topics in Endocrine and Endocrine-Related Diseases","author":"Jaffrain-Rea","year":"2013"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-020-00269-9","article-title":"Update on Pituitary Adenomas in the 2017 World Health Organization Classification: Innovations and Perspectives","volume":"20","author":"Kontogeorgos","year":"2021","journal-title":"Hormones (Athens)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00820-y","article-title":"Pituitary Neuroendocrine Tumors: A Model for Neuroendocrine Tumor Classification","volume":"34","author":"Asa","year":"2021","journal-title":"Mod Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3171\/2018.4.JNS172148","article-title":"Developing an Optimal Follow-Up Strategy Based on the Natural History of Nonfunctioning Pituitary Adenomas","volume":"131","author":"Kim","year":"2018","journal-title":"J Neurosurg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.9.7819","article-title":"Surgical Management of GH-Secreting Pituitary Adenomas: An Outcome Study Using Modern Remission Criteria","volume":"86","author":"Kreutzer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","article-title":"Different Patterns of Allelic Loss (Loss of Heterozygosity) in Recurrent Human Pituitary Tumors Provide Evidence for Multiclonal Origins","volume":"6","author":"Clayton","year":"2000","journal-title":"Clin Cancer Res"},{"key":"B13","volume-title":"WHO Classification of Tumours of Endocrine Organs","author":"Lloyd","year":"2017"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2010.02.043","article-title":"Proliferation Markers of Human Pituitary Tumors: Contribution of a Genome-Wide Transcriptome Approach","volume":"326","author":"Wierinckx","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/nan.12568","article-title":"Invited Review: Pathology of Pituitary Neuroendocrine Tumours: Present Status, Modern Diagnostic Approach, Controversies and Future Perspectives From a Neuropathological and Clinical Standpoint","volume":"46","author":"Manojlovic-Gacic","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1210\/jc.78.1.89","article-title":"Ras Mutations in Human Prolactinomas and Pituitary Carcinomas","volume":"78","author":"Cai","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.4.842","article-title":"H-Ras Mutations in Human Pituitary Carcinoma Metastases","volume":"78","author":"Pei","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2007.10.004","article-title":"Role of Ki-67 Proliferation Index and P53 Expression in Predicting Progression of Pituitary Adenomas","volume":"39","author":"Gejman","year":"2008","journal-title":"Hum Pathol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-021-01151-6","article-title":"Identification of Mutant K-RAS in Pituitary Macroadenoma","volume":"24","author":"Aran","year":"2021","journal-title":"Pituitary"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/15275","article-title":"Early Involvement of Estrogen-Induced Pituitary Tumor Transforming Gene and Fibroblast Growth Factor Expression in Prolactinoma Pathogenesis","volume":"5","author":"Heaney","year":"1999","journal-title":"Nat Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.2.5432","article-title":"Pituitary Tumor Transforming Gene (PTTG) Expression in Pituitary Adenomas","volume":"84","author":"Zhang","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/me.2005-0137","article-title":"Pituitary Hypoplasia in Pttg-\/- Mice is Protective for Rb+\/- Pituitary Tumorigenesis","volume":"19","author":"Chesnokova","year":"2005","journal-title":"Mol Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02630.x","article-title":"Pituitary Tumour Transforming Gene (PTTG) Expression Correlates With the Proliferative Activity and Recurrence Status of Pituitary Adenomas: A Clinical and Immunohistochemical Study","volume":"65","author":"Filippella","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/er.2006-0042","article-title":"Pituitary Tumor-Transforming Gene: Physiology and Implications for Tumorigenesis","volume":"28","author":"Vlotides","year":"2007","journal-title":"Endocr Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S1575-0922(10)70006-1","article-title":"[Rol of Pituitary Tumour-Transforming Gene (PTTG) in the Pituitary Adenomas]","volume":"57","author":"Sanchez-Ortiga","year":"2010","journal-title":"Endocrinol Nutr"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-18-0028","article-title":"Protein Stabilization by RSUME Accounts for PTTG Pituitary Tumor Abundance and Oncogenicity","volume":"25","author":"Fuertes","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.3.5658","article-title":"An Intronless Homolog of Human Proto-Oncogene hPTTG is Expressed in Pituitary Tumors: Evidence for hPTTG Family","volume":"84","author":"Prezant","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2007.08.006","article-title":"The Emerging Role of Pituitary Tumour Transforming Gene (PTTG) in Endocrine Tumourigenesis","volume":"278","author":"Kim","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"B29","article-title":"Biomarkers of Pituitary Neoplasms","volume":"32","author":"Sav","year":"2012","journal-title":"Anticancer Res"},{"key":"B30","article-title":"Loss of pRb Expression in Pituitary Adenomas is Associated With Methylation of the RB1 CpG Island","volume":"60","author":"Simpson","year":"2000","journal-title":"Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.6.8517","article-title":"Expression of Phosphorylated P27(Kip1) Protein and Jun Activation Domain-Binding Protein 1 in Human Pituitary Tumors","volume":"87","author":"Korbonits","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1677\/JME-08-0146","article-title":"Cell Cycle Control of Pituitary Development and Disease","volume":"42","author":"Quereda","year":"2009","journal-title":"J Mol Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2010.03.017","article-title":"Cyclins and Their Related Proteins in Pituitary Tumourigenesis","volume":"326","author":"Musat","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65323-0","article-title":"Apoptosis in Nontumorous and Neoplastic Human Pituitaries: Expression of the Bcl-2 Family of Proteins","volume":"154","author":"Kulig","year":"1999","journal-title":"Am J Pathol"},{"key":"B35","first-page":"8","article-title":"Indices of Apoptosis and Proliferation as Potential Prognostic Markers in non-Functioning Pituitary Adenomas","volume":"23","author":"Ibrahim","year":"2004","journal-title":"Clin Neuropathol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1159\/000095526","article-title":"Predictive Markers of Pituitary Adenoma Behavior","volume":"83","author":"Kontogeorgos","year":"2006","journal-title":"Neuroendocrinology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-013-0481-5","article-title":"Apoptosis: Its Role in Pituitary Development and Neoplastic Pituitary Tissue","volume":"17","author":"Guzzo","year":"2014","journal-title":"Pituitary"},{"key":"B38","article-title":"Apoptosis in Human Pituitary Adenomas: A Morphologic and in Situ End-Labeling Study","volume":"10","author":"Kontogeorgos","year":"1997","journal-title":"Mod Pathol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/01913120121070","article-title":"Ultrastructural Features of Apoptosis in Human Pituitary Adenomas","volume":"25","author":"Vidal","year":"2001","journal-title":"Ultrastruct Pathol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1159\/000079047","article-title":"Morphology, Molecular Regulation and Significance of Apoptosis in Pituitary Adenomas","volume":"32","author":"Kapranos","year":"2004","journal-title":"Front Horm Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.2010.02010.x","article-title":"Cell Life and Death in the Anterior Pituitary Gland: Role of Oestrogens","volume":"22","author":"Seilicovich","year":"2010","journal-title":"J Neuroendocrinol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1177\/030089160308900112","article-title":"Expression of Bcl-2, Bax and P53 Proteins in Pituitary Adenomas: An Immunohistochemical Study","volume":"89","author":"Ozer","year":"2003","journal-title":"Tumori"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1023\/B:PITU.0000011173.04191.37","article-title":"Correlation of Bcl-2 and Bax With Apoptosis in Human Pituitary Adenomas","volume":"6","author":"Sambaziotis","year":"2003","journal-title":"Pituitary"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-006-4568-6","article-title":"A Novel Paraptosis Pathway Involving LEI\/L-DNaseII for EGF-Induced Cell Death in Somato-Lactotrope Pituitary Cells","volume":"11","author":"Fombonne","year":"2006","journal-title":"Apoptosis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.taap.2009.07.002","article-title":"Bromocriptine Induces Parapoptosis as the Main Type of Cell Death Responsible for Experimental Pituitary Tumor Shrinkage","volume":"240","author":"Palmeri","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s004180100307","article-title":"Sexual Dimorphism of Apoptosis in Lactotrophs Induced by Bromocryptine","volume":"116","author":"Aoki","year":"2001","journal-title":"Histochem Cell Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.12.128","article-title":"PGAM5-CypD Pathway is Involved in Bromocriptine-Induced RIP3\/MLKL-Dependent Necroptosis of Prolactinoma Cells","volume":"111","author":"Zhang","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-021-00919-y","article-title":"Evaluation of the Expression of Necroptosis Pathway Mediators and its Association With Tumor Characteristics in Functional and non-Functional Pituitary Adenomas","volume":"22","author":"Khamseh","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/35077213","article-title":"Proliferation, Cell Cycle and Apoptosis in Cancer","volume":"411","author":"Evan","year":"2001","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4400950","article-title":"On the Origin, Evolution, and Nature of Programmed Cell Death: A Timeline of Four Billion Years","volume":"9","author":"Ameisen","year":"2002","journal-title":"Cell Death Differ"},{"key":"B51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1535-6108(02)00024-7","article-title":"A Matter of Life and Death","volume":"1","author":"Green","year":"2002","journal-title":"Cancer Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0091-3022(03)00012-8","article-title":"Molecular Defects in the Pathogenesis of Pituitary Tumours","volume":"24","author":"Levy","year":"2003","journal-title":"Front Neuroendocrinol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nature03098","article-title":"Intrinsic Tumour Suppression","volume":"432","author":"Lowe","year":"2004","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nm1087","article-title":"Cancer Genes and the Pathways They Control","volume":"10","author":"Vogelstein","year":"2004","journal-title":"Nat Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2014.64","article-title":"Aggressive Pituitary Adenomas\u2013Diagnosis and Emerging Treatments","volume":"10","author":"Di Ieva","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12609","article-title":"Understanding Cell Cycle and Cell Death Regulation Provides Novel Weapons Against Human Diseases","volume":"281","author":"Wiman","year":"2017","journal-title":"J Intern Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2018.1527689","article-title":"Mathematical Models of Tumour Cell Proliferation: A Review of the Literature","volume":"18","author":"Jarrett","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.21571.1","article-title":"The Essentials of Developmental Apoptosis","volume":"9","author":"Voss","year":"2020","journal-title":"F1000Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094723","article-title":"Interplay Between Cell Death and Cell Proliferation Reveals New Strategies for Cancer Therapy","volume":"23","author":"Loftus","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.drup.2007.01.003","article-title":"Cell Survival, Cell Death and Cell Cycle Pathways are Interconnected: Implications for Cancer Therapy","volume":"10","author":"Maddika","year":"2007","journal-title":"Drug Resist Update"},{"key":"B61","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00005-012-0205-y","article-title":"Autophagy, Apoptosis, Mitoptosis and Necrosis: Interdependence Between Those Pathways and Effects on Cancer","volume":"61","author":"Chaabane","year":"2013","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2014.0219","article-title":"Cancer Across the Tree of Life: Cooperation and Cheating in Multicellularity","volume":"370","author":"Aktipis","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.4161\/auto.23922","article-title":"Autophagy and Senescence: A Partnership in Search of Definition","volume":"9","author":"Gewirtz","year":"2013","journal-title":"Autophagy"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201439245","article-title":"Senescence and Apoptosis: Dueling or Complementary Cell Fates","volume":"15","author":"Childs","year":"2014","journal-title":"EMBO Rep"},{"key":"B65","first-page":"30","article-title":"The Ecology of Tumors: By Perturbing the Microenvironment, Wounds and Infection may be Key to Tumor Development","volume":"20","author":"Kenny","year":"2006","journal-title":"Scientist"},{"key":"B66","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/156652410791065363","article-title":"Perspectives on Tissue Interactions in Development and Disease","volume":"10","author":"Strand","year":"2010","journal-title":"Curr Mol Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-015-9709-6","article-title":"Molecular Mechanisms Underlying Pituitary Pathogenesis","volume":"54","author":"Sapochnik","year":"2016","journal-title":"Biochem Genet"},{"key":"B68","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/pmic.200300408","article-title":"A Reference Map of a Human Pituitary Adenoma Proteome","volume":"3","author":"Zhan","year":"2003","journal-title":"Proteomics"},{"key":"B69","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1755-8794-3-13","article-title":"Signaling Pathway Networks Mined From Human Pituitary Adenoma Proteomics Data","volume":"3","author":"Zhan","year":"2010","journal-title":"BMC Med Genomics"},{"key":"B70","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12920-014-0069-6","article-title":"Heterogeneity Analysis of the Proteomes in Clinically Nonfunctional Pituitary Adenomas","volume":"7","author":"Zhan","year":"2014","journal-title":"BMC Med Genomics"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2016.00054","article-title":"Human Pituitary Adenoma Proteomics: New Progresses and Perspectives","volume":"7","author":"Zhan","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00835","article-title":"Multiomics-Based Signaling Pathway Network Alterations in Human Non-Functional Pituitary Adenomas","volume":"10","author":"Long","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00290","article-title":"The Epigenomics of Pituitary Adenoma","volume":"10","author":"Hauser","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.2217\/ije-2019-0006","article-title":"Epigenetic Dysregulation in Pituitary Tumors","volume":"6","author":"Shariq","year":"2019","journal-title":"Int J Endocrine Oncol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.596554","article-title":"Genetic and Epigenetic Causes of Pituitary Adenomas","volume":"11","author":"Chang","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B76","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1210\/endrev\/bnaa006","article-title":"Novel Insights Into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms","volume":"41","author":"Srirangam Nadhamuni","year":"2020","journal-title":"Endocrine Rev"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1210\/en.2012-1231","article-title":"Epigenomic Silencing of the BMP-4 Gene in Pituitary Adenomas: A Potential Target for Epidrug-Induced Re-Expression","volume":"153","author":"Yacqub-Usman","year":"2012","journal-title":"Endocrinology"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2012.54","article-title":"The Pituitary Tumour Epigenome: Aberrations and Prospects for Targeted Therapy","volume":"8","author":"Yacqub-Usman","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2017.07.011","article-title":"Epigenetics of Pituitary Tumors: Pathogenetic and Therapeutic Implications","volume":"469","author":"Ezzat","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0578","article-title":"Deoxyribonucleic Acid Methyltransferase 3B Promotes Epigenetic Silencing Through Histone 3 Chromatin Modifications in Pituitary Cells","volume":"93","author":"Zhu","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.910608","article-title":"Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3a (DNMT3A) Is Associated With Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas","volume":"24","author":"Ma","year":"2018","journal-title":"Med Sci Monit"},{"key":"B82","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.mce.2009.12.028","article-title":"Chromatin Remodeling and Histone Modifications in Pituitary Tumors","volume":"326","author":"Tateno","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.2011.02129.x","article-title":"Histone Acetylation Patterns of Typical and Atypical Pituitary Adenomas Indicate Epigenetic Shift of These Tumours","volume":"23","author":"Ebrahimi","year":"2011","journal-title":"J Neuroendocrinol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.10834","article-title":"Histone Deacetylase 11 Suppresses P53 Expression in Pituitary Tumor Cells","volume":"41","author":"Wang","year":"2017","journal-title":"Cell Biol Int"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-018-0881-7","article-title":"Differential Gene Expression of Sirtuins Between Somatotropinomas and Nonfunctioning Pituitary Adenomas","volume":"21","author":"Grande","year":"2018","journal-title":"Pituitary"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/S1673-8527(08)60122-8","article-title":"Histone Acetyltransferase P300 Regulates the Expression of Human Pituitary Tumor Transforming Gene (hPTTG)","volume":"36","author":"Li","year":"2009","journal-title":"J Genet Genomics"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.4161\/cc.7.17.6597","article-title":"Mechanisms of microRNA Deregulation in Human Cancer","volume":"7","author":"Deng","year":"2008","journal-title":"Cell Cycle"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2634","article-title":"Causes and Consequences of microRNA Dysregulation in Cancer","volume":"10","author":"Croce","year":"2009","journal-title":"Nat Rev Genet"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.20282","article-title":"miR-15a and miR-16-1 Down-Regulation in Pituitary Adenomas","volume":"204","author":"Bottoni","year":"2005","journal-title":"J Cell Physiol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.20832","article-title":"Identification of Differentially Expressed microRNAs by Microarray: A Possible Role for microRNA Genes in Pituitary Adenomas","volume":"210","author":"Bottoni","year":"2007","journal-title":"J Cell Physiol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2008.12.013","article-title":"Microtranscriptome Regulation by Gonadotropin-Releasing Hormone","volume":"302","author":"Yuen","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1746-1596-5-79","article-title":"Differential Expression of microRNAs in GH-Secreting Pituitary Adenomas","volume":"5","author":"Mao","year":"2010","journal-title":"Diagn Pathol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.126441","article-title":"MicroRNAs Regulate Pituitary Development, and microRNA 26b Specifically Targets Lymphoid Enhancer Factor 1 (Lef-1), Which Modulates Pituitary Transcription Factor 1 (Pit-1) Expression","volume":"285","author":"Zhang","year":"2010","journal-title":"J Biol Chem"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-011-9167-6","article-title":"MicroRNAs in the Human Pituitary","volume":"22","author":"Sivapragasam","year":"2011","journal-title":"Endocr Pathol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3482","article-title":"Altered microRNA Expression Profile in Human Pituitary GH Adenomas: Down-Regulation of miRNA Targeting HMGA1, HMGA2, and E2F1","volume":"97","author":"D'angelo","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.557","article-title":"Downregulation of HMGA-Targeting microRNAs has a Critical Role in Human Pituitary Tumorigenesis","volume":"31","author":"Palmieri","year":"2012","journal-title":"Oncogene"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-017-9794-9","article-title":"Novel Biomarkers for Non-Functioning Invasive Pituitary Adenomas Were Identified by Using Analysis of microRNAs Expression Profile","volume":"55","author":"Wu","year":"2017","journal-title":"Biochem Genet"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.4172\/2157-2518.1000165","article-title":"Genomic Instability and Cancer","volume":"5","author":"Yao","year":"2014","journal-title":"J Carcinog Mutagen"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1023\/a:1025313214951","article-title":"Genomic Instability in Pituitary Adenomas","volume":"5","author":"Szymas","year":"2002","journal-title":"Pituitary"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2016.114","article-title":"The Genome-Wide Mutational Landscape of Pituitary Adenomas","volume":"26","author":"Song","year":"2016","journal-title":"Cell Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"97","DOI":"10.5603\/EP.a2020.0084","article-title":"Chromosomal and Oxidative DNA Damage in non-Functioning Pituitary Adenomas","volume":"72","author":"Bitgen","year":"2021","journal-title":"Endokrynol Pol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.2.387","article-title":"Molecular Genetic Studies of Sporadic Pituitary Tumors","volume":"78","author":"Boggild","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.10216","article-title":"Genome-Wide Amplification and Allelotyping of Sporadic Pituitary Adenomas Identify Novel Regions of Genetic Loss","volume":"37","author":"Simpson","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1172\/JCI138540","article-title":"DNA Damage and Growth Hormone Hypersecretion in Pituitary Somatotroph Adenomas","volume":"130","author":"Ben-Shlomo","year":"2020","journal-title":"J Clin Invest"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1011","article-title":"ATM and Related Protein Kinases: Safeguarding Genome Integrity","volume":"3","author":"Shiloh","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2007.05.002","article-title":"Genome Maintenance Mechanisms are Critical for Preventing Cancer as Well as Other Aging-Associated Diseases","volume":"128","author":"Hoeijmakers","year":"2007","journal-title":"Mech Ageing Dev"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/nature03482","article-title":"DNA Damage Response as a Candidate Anti-Cancer Barrier in Early Human Tumorigenesis","volume":"434","author":"Bartkova","year":"2005","journal-title":"Nature"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210881","article-title":"DNA Damage Signalling Guards Against Activated Oncogenes and Tumour Progression","volume":"26","author":"Bartek","year":"2007","journal-title":"Oncogene"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01401","article-title":"Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS Cohort","volume":"102","author":"Bengtsson","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B110","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1507\/endocrj.EJ17-0036","article-title":"Atypical Pituitary Adenoma With MEN1 Somatic Mutation Associated With Abnormalities of DNA Mismatch Repair Genes; MLH1 Germline Mutation and MSH6 Somatic Mutation","volume":"64","author":"Uraki","year":"2017","journal-title":"Endocr J"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-2206","article-title":"The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes","volume":"24","author":"Salomon","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0804810105","article-title":"P21(Cip1) Restrains Pituitary Tumor Growth","volume":"105","author":"Chesnokova","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B113","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1530\/ERC-14-0333","article-title":"Evidence of Cellular Senescence During the Development of Estrogen-Induced Pituitary Tumors","volume":"22","author":"Sabatino","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-0974","article-title":"Senescence Mediates Pituitary Hypoplasia and Restrains Pituitary Tumor Growth","volume":"67","author":"Chesnokova","year":"2007","journal-title":"Cancer Res"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3365","article-title":"Mitochondria and Cancer","volume":"12","author":"Wallace","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B116","doi-asserted-by":"publisher","first-page":"814042","DOI":"10.1155\/2014\/814042","article-title":"Mitochondria in Health and Disease","volume":"2014","author":"Magalhaes","year":"2014","journal-title":"Oxid Med Cell Longev"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1586\/erm.09.60","article-title":"Key Signaling Molecules in Pituitary Tumors","volume":"9","author":"Tanase","year":"2009","journal-title":"Expert Rev Mol Diagn"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00690","article-title":"Mitochondrial Dysfunction Pathway Networks and Mitochondrial Dynamics in the Pathogenesis of Pituitary Adenomas","volume":"10","author":"Li","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00330","article-title":"The MAPK Pathway-Based Drug Therapeutic Targets in Pituitary Adenomas","volume":"10","author":"Lu","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.565748","article-title":"Targeting Nrf2-Mediated Oxidative Stress Response Signaling Pathways as New Therapeutic Strategy for Pituitary Adenomas","volume":"12","author":"Zhan","year":"2021","journal-title":"Front Pharmacol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/BF00735228","article-title":"Electron Microscopical Morphometry of GH Producing Pituitary Adenomas in Comparison With Normal GH Cells","volume":"411","author":"Saeger","year":"1987","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/BF00783026","article-title":"Oncocytomas and Null Cell Adenomas of the Human Pituitary: Morphometric and In Vitro Functional Comparison","volume":"413","author":"Yamada","year":"1988","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.52.594","article-title":"Spindle Cell Oncocytoma of the Adenohypophysis With Marked Hypervascularity. Case Report","volume":"52","author":"Fujisawa","year":"2012","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"B124","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.freeradbiomed.2018.03.019","article-title":"Oxidative Stress and Mitochondrial Adaptive Shift During Pituitary Tumoral Growth","volume":"120","author":"Sabatino","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04366-5","article-title":"Lactate Dehydrogenase A Promotes the Invasion and Proliferation of Pituitary Adenoma","volume":"7","author":"An","year":"2017","journal-title":"Sci Rep"},{"key":"B126","first-page":"87","article-title":"Immunohistochemical Demonstration of Nitric Oxide Synthase (NOS) in the Normal Rat Pituitary Gland, Estrogen-Induced Rat Pituitary Tumor and Human Pituitary Adenomas","volume":"41","author":"Pawlikowski","year":"2003","journal-title":"Folia Histochem Cytobiol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-013-0046-4","article-title":"The Clinical and Pathological Significance of Nitric Oxide Synthase in Human Pituitary Adenomas: A Comparison With MIB-1","volume":"46","author":"Onishi","year":"2014","journal-title":"Endocrine"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-013-1292-2","article-title":"18beta-Glycyrrhetinic Acid Induces Apoptosis in Pituitary Adenoma Cells via ROS\/MAPKs-Mediated Pathway","volume":"116","author":"Wang","year":"2014","journal-title":"J Neurooncol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"17079","DOI":"10.1038\/s41598-017-16908-y","article-title":"Nitric Oxide Mediates Apoptosis and Mitochondrial Dysfunction and Plays a Role in Growth Hormone Deficiency by Nivalenol in GH3 Cells","volume":"7","author":"Huang","year":"2017","journal-title":"Sci Rep"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.23736\/S0390-5616.17.04083-8","article-title":"Decreased Nitric Oxide Serum Level After Pituitary Adenoma Resection","volume":"64","author":"Babula","year":"2020","journal-title":"J Neurosurg Sci"},{"key":"B131","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.toxlet.2018.05.041","article-title":"Protective Mechanisms Involving Enhanced Mitochondrial Functions and Mitophagy Against T-2 Toxin-Induced Toxicities in GH3 Cells","volume":"295","author":"Deyu","year":"2018","journal-title":"Toxicol Lett"},{"key":"B132","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/OTT.S70886","article-title":"Decreased Expression of APAF-1 and Increased Expression of Cathepsin B in Invasive Pituitary Adenoma","volume":"8","author":"Tanase","year":"2015","journal-title":"Onco Targets Ther"},{"key":"B133","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.tox.2018.03.006","article-title":"The Critical Role of P16\/Rb Pathway in the Inhibition of GH3 Cell Cycle Induced by T-2 Toxin","author":"Fatima","year":"2018","journal-title":"Toxicology"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.26752","article-title":"The Prolactin-Release Inhibitor Paeoniflorin Suppresses Proliferation and Induces Apoptosis in Prolactinoma Cells via the Mitochondria-Dependent Pathway","volume":"119","author":"Wei","year":"2018","journal-title":"J Cell Biochem"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1126\/science.1116801","article-title":"Suppressing Cancer: The Importance of Being Senescent","volume":"309","author":"Campisi","year":"2005","journal-title":"Science"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2233","article-title":"Cellular Senescence: When Bad Things Happen to Good Cells","volume":"8","author":"Campisi","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8924(01)82148-6","article-title":"Cellular Senescence as a Tumor-Suppressor Mechanism","volume":"11","author":"Campisi","year":"2001","journal-title":"Trends Cell Biol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.4161\/cc.8.5.8065","article-title":"Pituitary Adenoma Growth: A Model for Cellular Senescence and Cytokine Action","volume":"8","author":"Arzt","year":"2009","journal-title":"Cell Cycle"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017924","article-title":"Lineage-Specific Restraint of Pituitary Gonadotroph Cell Adenoma Growth","volume":"6","author":"Chesnokova","year":"2011","journal-title":"PLoS One"},{"key":"B140","doi-asserted-by":"publisher","first-page":"297","DOI":"10.14310\/horm.2002.1358","article-title":"Oncogene-Induced Senescence in Pituitary Adenomas and Carcinomas","volume":"11","author":"Alexandraki","year":"2012","journal-title":"Hormones (Athens)"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-015-9358-7","article-title":"Immunohistochemical Expression of P16 and P21 in Pituitary Tissue Adjacent to Pituitary Adenoma Versus Pituitary Tissue Obtained at Autopsy: Is There a Difference","volume":"26","author":"Manojlovic Gacic","year":"2015","journal-title":"Endocr Pathol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.7.2660-2672.2005","article-title":"Deregulated E2F Activity Induces Hyperplasia and Senescence-Like Features in the Mouse Pituitary Gland","volume":"25","author":"Lazzerini Denchi","year":"2005","journal-title":"Mol Cell Biol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2014.3062","article-title":"Pituitary Gene Expression Differs in D-Galactose-Induced Cell Senescence and Steroid-Induced Prolactinomas","volume":"11","author":"Zhang","year":"2015","journal-title":"Mol Med Rep"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13577","article-title":"Autocrine IL-6 Mediates Pituitary Tumor Senescence","volume":"8","author":"Sapochnik","year":"2017","journal-title":"Oncotarget"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2772","article-title":"Senescence in Tumours: Evidence From Mice and Humans","volume":"10","author":"Collado","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2010.02.012","article-title":"Pituitary Senescence: The Evolving Role of Pttg","volume":"326","author":"Chesnokova","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1159\/000192443","article-title":"Pituitary Tumour-Transforming Gene (PTTG) and Pituitary Senescence","author":"Chesnokova","year":"2009","journal-title":"Horm Res"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1159\/000245928","article-title":"Regulation of Pituitary Function by Cytokines","volume":"72","author":"Haedo","year":"2009","journal-title":"Horm Res"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1530\/JME-17-0026","article-title":"Programmed Cell Senescence: Role of IL-6 in the Pituitary","volume":"58","author":"Sapochnik","year":"2017","journal-title":"J Mol Endocrinol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1080\/23723556.2018.1435180","article-title":"Senescence Drives non-Cell Autonomous Tumorigenesis in the Pituitary Gland","volume":"5","author":"Gonzalez-Meljem","year":"2018","journal-title":"Mol Cell Oncol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/S0739-7240(98)00027-7","article-title":"Regulation and Role of Intrapituitary IL-6 Production by Folliculostellate Cells","volume":"15","author":"Renner","year":"1998","journal-title":"Domest Anim Endocrinol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1126\/science.1099993","article-title":"Autophagy in Health and Disease: A Double-Edged Sword","volume":"306","author":"Shintani","year":"2004","journal-title":"Science"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2254","article-title":"Role of Autophagy in Cancer","volume":"7","author":"Mathew","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-5023","article-title":"The Double-Edged Sword of Autophagy Modulation in Cancer","volume":"15","author":"White","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1599207","article-title":"Autophagy: Process and Function","volume":"21","author":"Mizushima","year":"2007","journal-title":"Genes Dev"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1038\/nature06639","article-title":"Autophagy Fights Disease Through Cellular Self-Digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(78)90236-X","article-title":"Silent Corticotroph Cell Adenoma With Lysosomal Accumulation and Crinophagy. A Distinct Clinicopathologic Entity","volume":"64","author":"Kovacs","year":"1978","journal-title":"Am J Med"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1007\/BF00209972","article-title":"Morphometric Analysis of the Autophagic and Crinophagic Lysosomal Systems in Mammotropes Throughout the Estrous Cycle of the Rat","volume":"220","author":"Poole","year":"1981","journal-title":"Cell Tissue Res"},{"key":"B159","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/BF00524761","article-title":"Prolactin Crinophagy is Induced in the Estrogen-Stimulated Male Rat Pituitary","volume":"92","author":"Kuriakose","year":"1989","journal-title":"Histochemistry"},{"key":"B160","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41419-019-1694-y","article-title":"FOXP1-Induced lncRNA CLRN1-AS1 Acts as a Tumor Suppressor in Pituitary Prolactinoma by Repressing the Autophagy via Inactivating Wnt\/beta-Catenin Signaling Pathway","volume":"10","author":"Wang","year":"2019","journal-title":"Cell Death Dis"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-15-4272-5_12","article-title":"Autophagy and Pituitary Adenoma","volume":"1207","author":"Wu","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-021-09649-x","article-title":"Autophagy in Normal Pituitary and Pituitary Tumor Cells and its Potential Role in the Actions of Somatostatin Receptor Ligands in Acromegaly","volume":"22","author":"Tulipano","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5744","article-title":"Suppression of mTOR Pathway and Induction of Autophagy-Dependent Cell Death by Cabergoline","volume":"6","author":"Lin","year":"2015","journal-title":"Oncotarget"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2017.01.052","article-title":"Bromocriptine Induces Autophagy-Dependent Cell Death in Pituitary Adenomas","volume":"100","author":"Geng","year":"2017","journal-title":"World Neurosurg"},{"key":"B165","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41419-019-1526-0","article-title":"Bromocriptine and Cabergoline Induce Cell Death in Prolactinoma Cells via the ERK\/EGR1 and AKT\/mTOR Pathway Respectively","volume":"10","author":"Tang","year":"2019","journal-title":"Cell Death Dis"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-107243","article-title":"Preoperative Somatostatin Analogue Treatment Might Trigger Apoptosis and Autophagy in Tumor Tissues of Patients With Acromegaly: A Pilot Study","volume":"126","author":"Dagistanli","year":"2018","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-15-0042","article-title":"Autophagy in Endocrine Tumors","volume":"22","author":"Weckman","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1210\/me.2006-0293","article-title":"The Notch Signaling System is Present in the Postnatal Pituitary: Marked Expression and Regulatory Activity in the Newly Discovered Side Population","volume":"20","author":"Chen","year":"2006","journal-title":"Mol Endocrinol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0707886105","article-title":"SOX2-Expressing Progenitor Cells Generate All of the Major Cell Types in the Adult Mouse Pituitary Gland","volume":"105","author":"Fauquier","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B170","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-17-0258","article-title":"Stem\/progenitor Cells in Pituitary Organ Homeostasis and Tumourigenesis","volume":"236","author":"Haston","year":"2018","journal-title":"J Endocrinol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1159\/000375502","article-title":"Pituitary Cell Turnover: From Adult Stem Cell Recruitment Through Differentiation to Death","volume":"101","author":"Garcia-Lavandeira","year":"2015","journal-title":"Neuroendocrinology"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17010075","article-title":"Regulatory System for Stem\/Progenitor Cell Niches in the Adult Rodent Pituitary","volume":"17","author":"Yoshida","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00339","article-title":"The Stem Cell Connection of Pituitary Tumors","volume":"8","author":"Vankelecom","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2005.04.023","article-title":"Identification and Enrichment of Colony-Forming Cells From the Adult Murine Pituitary","volume":"308","author":"Lepore","year":"2005","journal-title":"Exp Cell Res"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2010.07523.x","article-title":"Pituitary Stem\/Progenitor Cells: Embryonic Players in the Adult Gland","volume":"32","author":"Vankelecom","year":"2010","journal-title":"Eur J Neurosci"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2013.07.006","article-title":"Mobilized Adult Pituitary Stem Cells Contribute to Endocrine Regeneration in Response to Physiological Demand","volume":"13","author":"Rizzoti","year":"2013","journal-title":"Cell Stem Cell"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-315500","article-title":"The Screening and Management of Pituitary Dysfunction Following Traumatic Brain Injury in Adults: British Neurotrauma Group Guidance","volume":"88","author":"Tan","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00313","article-title":"Pituispheres Contain Genetic Variants Characteristic to Pituitary Adenoma Tumor Tissue","volume":"11","author":"Peculis","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00054","article-title":"Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells","volume":"11","author":"Wurth","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.14470","article-title":"PROP1 Triggers Epithelial-Mesenchymal Transition-Like Process in Pituitary Stem Cells","volume":"5","author":"Perez Millan","year":"2016","journal-title":"Elife"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00077.2016","article-title":"The Expansion of Adult Stem\/Progenitor Cells and Their Marker Expression Fluctuations are Linked With Pituitary Plastic Adaptation During Gestation and Lactancy","volume":"311","author":"Vaca","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B182","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mce.2016.10.005","article-title":"Stem Cells and Their Role in Pituitary Tumorigenesis","volume":"445","author":"Carreno","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-017-0803-y","article-title":"Pituitary Adenomas, Stem Cells, and Cancer Stem Cells: What's New","volume":"41","author":"Caffarini","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13051","article-title":"Changes of Stem Cell Niche During Experimental Pituitary Tumor Development","volume":"33","author":"Guido","year":"2021","journal-title":"J Neuroendocrinol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2012.0290","article-title":"Regenerative Capacity of the Adult Pituitary: Multiple Mechanisms of Lactotrope Restoration After Transgenic Ablation","volume":"21","author":"Fu","year":"2012","journal-title":"Stem Cells Dev"},{"key":"B186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12022-013-9235-1","article-title":"Stem Cells and Cancer Stem-Like Cells in Endocrine Tissues","volume":"24","author":"Lloyd","year":"2013","journal-title":"Endocr Pathol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1172\/JCI20401","article-title":"Mechanisms for Pituitary Tumorigenesis: The Plastic Pituitary","volume":"112","author":"Melmed","year":"2003","journal-title":"J Clin Invest"},{"key":"B188","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1530\/JOE-18-0462","article-title":"Organoids From Pituitary as a Novel Research Model Toward Pituitary Stem Cell Exploration","volume":"240","author":"Cox","year":"2019","journal-title":"J Endocrinol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.604519","article-title":"Pituitary Remodeling Throughout Life: Are Resident Stem Cells Involved","volume":"11","author":"Laporte","year":"2020","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.924942\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T04:31:33Z","timestamp":1656390693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.924942\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":189,"alternative-id":["10.3389\/fendo.2022.924942"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.924942","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"article-number":"924942"}}